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Abstract: Background: Several automated systems had been developed in order to reduce inter-observer variability in 
indirect immunofluorescence (IIF) interpretation. We aimed to evaluate the performance of a processing system in 
antinuclear antibodies (ANA) screening on HEp-2 cells. 
Patients and Methods: This study included 64 ANA-positive sera and 107 ANA-negative sera that underwent IIF on two 
commercial kits of HEp-2 cells (BioSystems® and Euroimmun®). IIF results were compared with a novel automated 
interpretation system, the “CyclopusCADImmuno®” (CAD). 
Results: All ANA-positive sera images were recognized as positive by CAD (sensitivity = 100%), while 17 (15.9%) of the 
ANA-negative sera images were interpreted as positive (specificity = 84.1%), =0.799 (SD=0.045). Comparison of IIF 
pattern determination between human and CAD system revealed on HEp-2 (BioSystems®), a complete concordance in 
6 (9.37%) sera, a partial concordance (sharing of at least 1 pattern) in 42 (65.6%) cases and in 16 (25%) sera the 
pattern interpretation was discordant. Similarly, on HEp-2 (Euroimmun®) the concordance in pattern interpretation was 
total in 5 (7.8%) sera, partial in 39 (60.9%) and absent in 20 (31.25%). For both tested HEp-2 cells kits agreement was 
enhanced for the most common patterns, homogenous, fine speckled and coarse speckled. While there was an issue in 
identification of nucleolar, dots and nuclear membranous patterns by CAD. 
Conclusion: Assessment of ANA by IIF on HEp-2 cells using the automated interpretation system, the 
“CyclopusCADImmuno®” is a reliable method for positive/negative differentiation. Continuous integration of IIF images 
would improve the pattern identification by the CAD. 
Keywords: Autoantibodies, HEp-2, Immunofluorescence, autoimmune diseases, automated screening, 
standardization. 
INTRODUCTION 
Antinuclear antibodies (ANA) are clinically useful 
markers of several chronic autoimmune diseases 
called connectivitis. Indirect immunofluorescence (IIF) 
which was described in 1958 has become the standard 
method for the detection of several autoantibodies 
including ANA [1]. In spite of the development of 
several assays like ELISA or microarrays, IIF on HEp-2 
cells remains the “gold standard” for ANA screening [2]. 
Currently, there is no consensus on the potential  
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factors that could influence IIF results (culture 
condition, fixative procedure of HEp-2 cells, starting 
dilution, antiglobuline specificity, etc.). In practice, most 
laboratories perform ANA screening at the 1/80
th
 
dilution or less frequently at 1/160
th
. It is worth to note 
that 10 to 15% of healthy adults has positive ANA at 
the 1/80
th
titer and 5% at 1/160
th
, and this frequency 
tends to increase with aging mostly in women after 60 
years old. Obviously, positivity at these titers has no 
clinical significance.  
The type and the localization of the fluorescence 
define the IIF pattern. The terminology of IIF images is 
not consensual, however the revised nomenclature 
made within the CANTOR project [1] would provide 
homogeneity in image definitions. This revised 
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taxonomy outlines 6 groups of patterns: 1) 
Membranous nuclear patterns, 2) Nucleoplasmic 
patterns, 3) nucleolar patterns, 4) spindle apparatus 
patterns, 5) Cytoplasmic patterns and 6) negative [1].  
Besides, inter-laboratories and intra-laboratory 
discrepancies in terms of negative or positive aspects 
and in terms of pattern recognition depends on:  
• The variability inherent to the used kit of HEp-2 
cells 
• The reading system: microscope sensitivity, and 
the kind of the used lamp (HBO or LED) 
• The threshold of positivity and the pattern 
identification, in fact usually several patterns 
overlap. Therefore, the skill of the observer is a 
key point.  
Since the increase of ANA test requests, which led 
to speed up the reading time on microscope, the lack of 
standardization and inter-observer variability, several 
automated systems of image reading had been 
developed. These systems would be used in second 
reading after that of the human expert or within the 
framework of apprenticeship of the inexperienced 
juniors. Various stages are necessary: 1) the 
acquisition automated by the image, 2) a quality control 
of the image, 3) the segmentation of the image for the 
detection of the object, 4) the extraction of the 
characteristics to describe the object and the 
classification of the detected objects. The acquisition of 
a quality image depends on the automated tuning, on 
the adjustment of the intensity of the image, on the 
quality control of the sharpness and on the luminosity, 
on the detection of artifacts, on the real time evaluation 
of the aspect of fluorescence and on the calibration of 
the fluorescence. The advantage is to obtain 
comparable results between laboratories, which require 
a standardization of the IIF with a measure of the 
intensity in units of fluorescence and a calibrated 
system allowing in particular comparable studies of 
groups in various laboratories. The system has to 
allow, thanks to adapted software, the memorization of 
the acquired images and their archiving for possible 
comparisons. 
Different systems are in development and, to our 
knowledges, those currently proposed for routine 
analysis with image interpretation are [3]: 
• Aklides System (Medipan, Berlin, Germany) on 
HEp-2: negative / positive discrimination, 5 
patterns 
• Nova View (Werfen, INOVA Diagnostics Inc., 
Barcelona, Spain) on HEp-2: negative / positive 
discrimination, 6 patterns 
• Zenit G-Sight A (Menarini Diagnostics, Florence, 
Italy) on HEp-2 or HEp-2000: negative / positive 
discrimination, 5 patterns 
• EuroPattern (Euroimmun, Lübeck, Germany) on 
HEp-2 negative / positive discrimination, 5 
patterns 
• Helios (Aesku Diagnostics, Wendelsheim, 
Germany) on HEp-2: negative / positive 
discrimination 
• Image Navigator (Immuno Concepts, 
Sacramento, United States) on HEp-2: negative / 
positive discrimination. 
The present study was undertaken to evaluate the 
performances of a new system, the 
CyclopusCADImmuno®, which is still undergoing a 
process of development and education.  
MATERIAL AND METHODS 
Patients and Controls 
In this study, 64 ANA-positive sera from patients 
with a confirmed diagnosis of systemic lupus 
erythematosus (SLE) and 107 ANA-negative sera from 
healthy blood donors were included. The antigen-
targets of the collected ANA-positive sera were 
previously determined by both IIF on CrithidiaLucilae 
for the anti-dsDNA antibodies and immunodot 
(Innolia®) for the antibodies to extractable nuclear 
antigens (ENA). Sixty-three (98.4%) of the ANA-
positive sera contained at least 2 or more target 
specificities. ANA titers were considered high when it 
surpassed the 1/320
th
 dilution. Characteristics of the 
ANA-positive sera are recorded in Table 1. 
All patients and controls gave written informed 
consent to participate in the study, and patient 
anonymity was preserved using documents and 
methods approved by the local Ethics committee of 
Charles Nicolle Hospital.  
Methods 
Indirect Immunofluorescence (IIF) Assay 
ANA detection was performed by IIF using 2 
commercial kits of HEp-2 cells: BioSystems® and 
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Euroimmun®. The complete incubation process was 
carried out manually: 1) first, the sera diluted at 1/80
th
 
were incubated with HEp-2 cells for 30 minutes at room 
temperature, 2) Second, 3 washing of 5 minutes each 
with PBS-Tween, 3) third, incubation with goat anti-
human IgG conjugated with fluorescein isothiocyanate 
and 4) fourth, after 3 washing, slides were embedded 
with a mounting medium. The ANA-negative sera were 
tested only in Euroimmun® HEp-2 kit. 
Human Evaluation of ANA 
Two skilled human experts whose experience in IIF 
analysis is about 18 and 9 years, respectively, 
evaluated the HEp-2 slides. Slides were interpreted 
within the Motic® BA310 Epi-LED FL microscope. The 
two experts worked blindly and independently without 
reference to each other or to the evaluated software’s 
readings. The reported patterns were: 1) homogenous, 
2) Speckled (fine speckled and/or coarse speckled), 3) 
nuclear dots, 4) nucleolar, 5) membranous nuclear, and 
6) negative. 
Automated Evaluation by the 
CyclopusCADImmuno® 
The system used in this study is the 
CyclopusCADImmuno®(CAD), powered by 
CyclopusCADsrl, a spin-off of University of Palermo. It 
consists of an informatics program for image analysis 
using artificial intelligence. The CAD is connected to a 
high-resolution camera (AESKU® LED 3002), which is 
itself linked to the same fluorescence microscope used 
by human experts. The CAD system and the high-
resolution camera were acquired through the AIDA 
project funded under the European Cooperation ENPI 
Italy-Tunisia. 
Statistical Analysis 
The agreement between human and CAD pattern 
recognition was evaluated using  statistics (SPSS 11 
Inc. Chicago, Illinois, USA). Based on  test, the 
agreement is poor when it ranges between 0 and 0.2, 
fair between 0.2 and 0.4, moderate between 0.4 and 
0.6, substantial between 0.6 and 0.8, and almost 
perfect between 0.8 and 1. When  is <0 the tests’ 
results are considered contradictory. Analysis of the 
influence of ANA titers on discrepancies between 
human and CAD interpretations was performed using 
chi-square test or fisher’s exact test for small numbers 
(SPSS 11 Inc. Chicago, Illinois, USA). Values of p < 
0.05 were considered to be statistically significant. 
RESULTS 
In total, 64 ANA-positive sera and 107 ANA-
negative sera were included in this study. Fifty 
(78.12%) sera had elevated titer of ANA and 63 
(98.4%) had at least two or more target-antigen 
specificities (Table 1). 
Table1: Characteristics of the 64 ANA-Positive Sera  
ANA-positive sera N=64 
Elevated titer  1/320th 50 (78.12%) 
Mixed pattern (human interpretation) 34 (53.1%) 
Two or more specificities of ANA 63 (98.4%) 
Anti-dsDNA antibodies 37 (57.8%) 
Anti-Sm antibodies 22 (34.37%) 
Anti-histone antibodies 28 (43.75%) 
Anti-ribosome antibodies 10 (15.6%) 
Anti-RNP antibodies 16 (25%) 
Anti-SSA/Ro52 30 (46.87%) 
Anti-SSA/Ro60 22 (34.37%) 
Anti-SSB/La 22 (34.37%) 
 
Comparison between BioSystems and Euroimmun 
Patterns’ Interpretation by Human Experts 
Agreement between the two human experts was 
total (100%). Globally 23 (35.9%) sera were in a total 
agreement for the IIF patterns detected on the two 
tested HEp-2 kits. A partial agreement (sharing of one 
IIF pattern) was found in 28 (43.75%) cases while a 
complete disparity was observed in 13 (20.3%) sera. 
Besides, agreement was moderate for the most 
common IIF patterns, homogenous, speckled, nuclear 
dots and membranous nuclear; =0.43, =0.56, 
=0.488 and =0.435 respectively. Agreement between 
the two tested HEp-2 kits was not correlated to the titer 
of ANA. 
Comparison between BioSystems and Euroimmun 
Patterns’ Interpretation by CyclopusCAD 
IIF patterns’ identification was totally concordant in 
17 (26.6%) sera, partly agreeing in 31 (48.5%) cases 
and completely disagreeing in only 16 (25%) samples. 
Agreement was poor for the homogenous and 
nucleolar patterns (=0.143 and =0.124), fair for the 
nuclear dot pattern (=0.333) and moderate for the 
speckled pattern (=0.421). Again, the agreement 
between the generated patterns of the two kits was not 
associated to ANA titer. 
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Performance of the CyclopusCAD in 
Negative/Positive Discrimination 
All ANA-positive sera of the lupus patients were 
recognized as positive, therefore its sensitivity is about 
100%. By contrast, 17 (15.9%) of the ANA-negative 
sera were recognized as positive by the CyclopusCAD 
system, hence its specificity is about 84.1% (Table 2). 
The concordance between human expert and software 
interpretations was 90.05% and agreement was almost 
perfect, =0.8.It is worth to note that all of the 17 ANA-
negative sera, which were identified by the 
CyclopusCAD as positive, had a cytoplasmic pattern.  
Table 2: Negative/Positive Discrimination of the 
CyclopusCAD 
CyclopusCADImmuno Positive Negative 
Lupus sera (ANA-positive) 64 0 
Control sera (ANA-negative) 17 90 
 value 0.8 
Sensitivity 100% 
Specificity 84.1% 
Positive predictive value 79% 
Negative predictive value 100% 
 
Performance of the CyclopusCAD in Identification 
of IIF Patterns on HEp-2 BioSystems® 
Using human experts as reference, the 
CyclopusCAD identified the rightIIF pattern in 6 
(9.37%) sera, while in 42 (65.6%) cases it recognized 
at least one of the mixed patterns. Inversely, in 16 
(25%) ANA-positive sera, the CAD did not pinpoint the 
correct IIF pattern. Comprehensive analysis of the 
patterns showed (Table 3): 
1) Moderate agreements for homogenous, 
speckled, and coarse speckled patterns 
2) Incongruity for nuclear dots, nucleolar, 
membranous nuclear patterns 
Besides, discrepancies in IIF pattern identification 
were encountered more frequently in sera with low 
titers of ANA but differences failed to reach the 
threshold of significance. 
Performance of the CyclopusCAD in Identification 
of IIF Patterns on HEp-2 Euroimmun® 
The CyclopusCAD recognized the correct IIF 
pattern in five (7.8%) cases, whereas it pinpointed one 
of the patterns in 39 (60.9%) sera. However, the CAD 
system failed to determine the exact pattern in 20 
(31.25%) cases. Detailed examination revealed (Table 
4): 
1) Moderate agreement for the coarse speckled 
pattern 
2) Fair agreement for homogenous, speckled and 
fine speckled patterns 
3) Poor agreement for nuclear dots, nucleolar and 
membranous nuclear patterns 
Furthermore, agreement was non-significantly 
better in case of high titers of ANA. 
DISCUSSION 
In the present study, we enrolled 64 ANA-positive 
sera from lupus-diagnosed patients and 107 ANA-
negative sera from healthy blood donors. The ANA-
positive sera were tested with both BioSystems® and 
Euroimmun® HEp-2 kits, while ANA-negative sera with 
Table 3: Agreements between Human Experts and the CyclopusCAD on HEp-2 BioSystems® 
Pattern 
Concordant 
(+ / -) 
Discordant 
Hum+/CAD- 
Discordant 
Hum-/CAD+ 
-value 
Homogenous 47 (17/30) 1 16 0.476 
Speckled 51 (39/12) 6 7 0.506 
Fine speckled 42 (17/25) 10 12 0.302 
Coarse speckled 51 (14/37) 4 8 0.537 
Nuclear dots 48 (0/48) 3 13 -0.082 
Nucleolar 45 (2/43) 6 13 0.013 
Membranous nuclear 37 (3/34) 24 3 0.034 
+: present, -: absent, Hum: human expert interpretation. 
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Euroimmun® only. All images were interpreted 
independently by two human experts and by the 
system undergoing evaluation, the 
CyclopusCADImmuno®. 
Comparative evaluation of the IIF patterns by 
human experts of the two tested HEp-2 kits revealed a 
concordance rate of 79.7% (35.9% complete 
agreement and 43.75% partial agreement). The best 
agreements involved specifically the most common IIF 
patterns, homogenous, speckled, nuclear dots and 
membranous nuclear. This results corroborates that the 
study of Copple et al. [4], in which 5 HEp-2 kits 
(Kallestad®, ImmunoConcepts®, Zeus®, Euroimmun® 
and Inova®) were compared using 372 sera (50 SLE, 
45 rheumatoid arthritis, 35 scleroderma, 20 Sjögren 
syndrome, 10 polymyositis, 12 reference sera from the 
CDC, 100 healthy blood donors and 100 sera from 
private laboratories). In this study, three skilled 
technologists made evaluation independently and 
blindly to sample classification and each other’s 
reading [4]. Concordance between the 3 readers varied 
from 96% to 99% [4]. Overall, the percentage of 
agreement for the 5 HEp-2 assays was 78% and varied 
from 44% in the scleroderma sera to 93% in the 
healthy blood donor group [4]. Furthermore, the 
authors reported discrepancies in titers’ estimation that 
reached for some specimens from to 1/80
th
 to 1/1280
th
 
[4]. It has been proposed that the use of a 
polyconjugate versus an IgG-specific conjugate results 
in variability among the 5 tested kits. In fact, 
polyconjugate (G, A and M) or total IgG (heavy and 
light chain) leads to the detection of the IgM class of 
ANA associated with rheumatoid arthritis, medications, 
and ageing, which are usually clinically insignificant. 
Besides, other factors such as culture conditions, 
fixation procedures, pH, assay temperature and many 
others may cause variability in both generation IIF 
pattern and ANA titers [5].  
Evaluation of the CyclopusCAD performance in 
negative/positive discrimination revealed comparable 
characteristics with commercialized systems (Table 5) 
[3]. Besides, in the present study the 17 sera that were 
falsely considered as ANA-positive had a cytoplasmic 
pattern. In fact, such cytoplasmic fluorescence is able 
to be considered as a nucleoplasmic pattern if the 
segmentation of the nuclei is not perfect. In this regard, 
Tonti et al. [6] proposed a novel approach to the 
segmentation of HEp-2 cells relying on: 
1) image acquisition 
2) image enhancement 
Table 4: Agreements between Human Experts and the CyclopusCAD on HEp-2 Euroimmun® 
Pattern 
Concordants 
(+ / -) 
Discordants 
Hum+/CAD- 
Discordants 
Hum-/CAD+ 
-value 
Homogenous 39 (25/14) 2 23 0.275 
Speckled 42 (29/13) 9 13 0.27 
Fine speckled 43 (11/32) 6 15 0.281 
Coarse speckled 58 (3/55) 4 2 0.45 
Nuclear dots 47 (0/47) 1 16 -0.03 
Nucleolar 58 (0/58) 2 4 -0.043 
Membranous nuclear 32 (0/32) 31 1 -0.031 
+: present, -: absent, Hum: human expert interpretation. 
Table 5: Comparative Analysis of the CyclopusCAD with Commercialized Systems [3] 
System Aklides EuroPattern Helios Image Navigator NovaView G-Sight CyclopusCAD 
Positive 90/92 89/92 90/92 88/92 86/92 91/92 64/64 
Negative 30/34 29/34 32/34 32/34 32/34 27/34 90/107 
Sensitivity 97.8 96.7 97.8 95.7 93.5 98.9 100 
Specificity 88.2 85.3 94.1 94.1 94.1 79.4 84.1 
PPV 95.7 94.6 97.8 97.7 97.7 92.8 79 
NPV 93.7 90.6 94.1 88.8 84.2 96.4 100 
PPV: positive predictive value, NPV: negative predictive value. 
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3) image classification as with smooth or rough 
texture 
4) Image normalization 
5) Marker extraction: identification of foreground 
regions and then separation of clustered cells 
6) Final and critical segmentation of the nuclei 
Otherwise, comparative analysis of IIF patterns’ 
interpretation between human experts and the 
CyclopusCAD revealed a good global concordance 
with either BioSystems® orEuroimmun®, 75% and 
68.75% respectively. These overall performances are 
close to that of EuroPattern® system, which was 
estimated at 79% [3]. While, it may surpass those of 
the three other systems, Aklides® (52%), NovaView® 
(54%) and G-Sight® (63%) [3]. It is worth to note that in 
the comparative study of these commercialized 
systems used only single pattern sera [3]. In another 
study, including sera with mixed pattern, the global 
performance of the EuroPattern® system was 
estimated at 48.9% [7]. Therefore, recognizing mixed 
patterns is critical. Moreover, it has been reported in 
Aklides system [8, 9], that distinction of patterns 
became problematic when there were 2 or 3 ANA 
specificities. Hence, considering the fact 98.4% of 
tested sera in our study had 2 or more specificities, the 
capacity of the CyclopusCAD, a system which is still 
ongoing licensing, is promising. 
To improve performance of automated systems, 
including the CyclopusCAD, a greater number of 
images must be acquired using 2 or 3 dilutions in order 
to ease interpretation of mixed patterns. It is of note, 
that aside from G-sight system which was developed 
with HEp-2 and HEp-2000 (transfected with SSA 
antigen), all other systems are to be considered as 
closed. In fact, the automated systems recognize 
patterns only on the HEp-2 kit with which it had been 
licensed. Consequently, if reproducibility between 
laboratories using the same system would be 
satisfying, a certain variability will persist between 
those using different systems. Therefore, 
commercialized and ongoing development systems 
need to be educated on a wide range of different HEp-
2 kits. 
Besides, the big laboratories with a high debit of 
ANA requests tend to have a diagnostic approach in 2 
stages. A first stage of positive/negative screening then 
a second stage of titration via serial dilutions. A 
calibration of the automated system according to the 
intensity of the fluorescence would allow obtaining 
straightaway and exactly the title of the AAN in a single 
stage. Eventually, the CyclopusCAD system will be 
associated with an automaton allowing the preparation 
of HEp-2 and connected directly with a microscope 
allowing a fast acquisition and an interpretation of the 
images and their archiving without any human 
interference.  
CONCLUSION 
Assessment of ANA by IIF on HEp-2 cells using the 
automated interpretation system, the 
“CyclopusCADImmuno®” is a reliable method for 
positive/negative differentiation. Continuous integration 
of IIF images would improve the pattern identification 
by the CAD.  
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